- Stocks
- Pharma & Healthcare
- JFL Life Scienc
JFL Life Scienc share price
NSE: JFLLIFEPharma & HealthcareDrug Manufacturers - Specialty & Generic
JFL Life Scienc at a glance
JFL Life Scienc (NSE: JFLLIFE) closed at ₹10.30 on 22 Oct 2026, down 4.63% on the day. With a market capitalisation of ₹34 Cr, it ranks 3302nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
At its last close the stock traded at 0.2× trailing earnings, against a return on equity of 10.5% in FY25. Over the past year the share price has fallen 29.0%. Its 52-week range is ₹8.55 (30 Mar 2026) to ₹14.70 (24 Dec 2025); the last close is 29.9% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹63 Cr (+437.5% year on year) and net profit ₹2 Cr (+1,975.0%), on a standalone basis. Promoters held 67.47% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹34 CrRank 3302 on NSE
- P/E (trailing)
- 0.2×
- Price to book
- 1.46×FY25
- EPS (TTM)
- ₹1.94to Q4 FY26
- ROE
- 10.5%FY25
- ROCE
- 17.9%FY25
- Debt to equity
- 0.27FY25
- Net profit margin
- 5.1%FY25
- Book value / share
- ₹11.96FY25
- 52-week high
- ₹14.7024 Dec 2025
- 52-week low
- ₹8.5530 Mar 2026
- 1-year return
- −29.0%
- RSI (14-day)
- 47.3
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −4.63% | −4.2% | +6.2% | +2.0% | −29.0% |
JFL Life Scienc quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹10 Cr | ₹40 Cr | ₹21 Cr | ₹12 Cr | ₹12 Cr | ₹30 Cr | ₹27 Cr | ₹63 Cr |
| Revenue YoY | — | — | +279.5% | −42.1% | +21.5% | −24.3% | +26.3% | +437.5% |
| Net profit | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Net profit YoY | — | — | +155.2% | −95.3% | −60.7% | +38.7% | +173.0% | +1,975.0% |
| Net margin | 20.0% | 3.6% | 3.5% | 0.7% | 6.5% | 6.6% | 7.5% | 2.6% |
| EPS | ₹1.74 | ₹1.29 | ₹0.22 | ₹0.03 | ₹0.23 | ₹0.60 | ₹0.61 | ₹0.50 |
JFL Life Scienc financials
| Item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Revenue | ₹34 Cr | ₹43 Cr | ₹47 Cr | ₹82 Cr |
| Operating profit | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹6 Cr |
| Net profit | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr |
| EPS (₹) | ₹4.12 | ₹2.90 | ₹3.01 | ₹1.26 |
| Cash from operations | ₹2 Cr | −₹9 Cr | ₹8 Cr | −₹4 Cr |
| Total debt | ₹8 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
| Shareholders' equity | ₹11 Cr | ₹32 Cr | ₹36 Cr | ₹39 Cr |
JFL Life Scienc shareholding pattern
| Holder | 10 Jun 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 67.47% | 67.47% | 67.47% | 67.47% | 67.47% | 67.47% |
| Non-institutions | 32.53% | 32.53% | 32.53% | 32.53% | 32.53% | 32.53% |
JFL Life Scienc vs peers
The listed Pharma & Healthcare companies nearest to JFL Life Scienc by market capitalisation.
Ask anything about JFL Life Scienc
Pivot answers on the live chart with evidence you can check, and tests strategies against JFLLIFE's own history. Try: “Why has JFLLIFE moved over the last three months?” · “Backtest a 50-day moving-average crossover on JFLLIFE over five years” · “Compare JFLLIFE with ROOPAIND on margins and valuation”
Frequently asked questions about JFL Life Scienc
What is the share price of JFL Life Scienc today?
JFL Life Scienc (NSE: JFLLIFE) last closed at ₹10.30 on 22 Oct 2026. Its 52-week high is ₹14.70 and its 52-week low is ₹8.55.
What is the market cap of JFL Life Scienc?
JFL Life Scienc's market capitalisation is ₹34 Cr (₹34 Cr) at the 22 Oct 2026 close, ranking 3302nd among the NSE companies Pivot tracks.
What is the P/E ratio of JFL Life Scienc?
JFL Life Scienc trades at a trailing P/E of 0.2.
What is the ROE and ROCE of JFL Life Scienc?
Return on equity was 10.5% in FY25 and return on capital employed was 17.9% in FY25 (standalone figures).
Is JFL Life Scienc a debt-free company?
No. JFL Life Scienc's debt-to-equity ratio was 0.27 in FY25, with total debt of ₹0 Cr.
What were JFL Life Scienc's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), JFL Life Scienc reported revenue of ₹63 Cr, +437.5% year on year, and net profit of ₹2 Cr, +1,975.0% year on year.
How has JFL Life Scienc stock performed over the last year?
JFL Life Scienc's share price has fallen 29.0% over the past year, +2.0% over three months and +6.2% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of JFL Life Scienc?
As of 30 Jun 2026: promoters 67.47%, non-institutions 32.53%.
Who are JFL Life Scienc's competitors?
The listed Pharma & Healthcare companies closest to JFL Life Scienc by market cap are Roopa Ind, Lasa Supergenerics, Chandra Bhagat, Sharma East Ind, Deccan Health C and Medi-Caps.
Is JFL Life Scienc a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out JFL Life Scienc's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on JFLLIFE against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with J · all NSE stocks · this page as text